Skip to main content
Premium Trial:

Request an Annual Quote

Applied Markets Watch: Seegene Licenses PCR Tech to BioMerieux for Food Safety

Premium

Seegene said this week that BioMérieux has licensed its DPO and TOCE technologies to develop multiplexed molecular tests for food safety.

Seegene's DPO (dual-priming oligonucleotide) and TOCE (tagging oligonucleotide capture and extension) technologies enable highly multiplexed assays based on real-time PCR.

DPO can be used to block extension of non-specifically primed templates, generating consistently high specificity; while TOCE enables simultaneous multiplexed assays by separating genes that have been amplified by real-time PCR technology based on differences in their melting temperatures, Seegene said.

"We believe that the adoption of our leading multiplexing technology will curtail future food contamination outbreaks, save lives, and help to grow this important market," Seegene CEO and CTO Jong-Yoon Chun said in a statement.

Financial terms of the agreement were not disclosed.

Seegene last year inked a similar licensing agreement for food safety testing with DuPont Nutrition & Health.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.